Efficacy of Radiofrequency Ablation Compared With Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma: A Comparative Survival Analysis

HPB - United Kingdom
doi 10.1016/j.hpb.2015.07.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Advanced Recurrent Hepatocellular Carcinoma: Treatment With Sorafenib Alone or in Combination With Transarterial Chemoembolization and Radiofrequency Ablation

Radiology
Nuclear MedicineRadiologyImaging
2018English

Severe Hepatic Necrosis After Combined Transarterial Chemoembolization and Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2016English

Medium or Large Hepatocellular Carcinoma: Sorafenib Combined With Transarterial Chemoembolization and Radiofrequency Ablation

Radiology
Nuclear MedicineRadiologyImaging
2018English

Clinical Efficacy of Chemoembolization With Simultaneous Radiofrequency Ablation for Treatment of Adrenal Metastases From Hepatocellular Carcinoma

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2018English

Efficacy of Radiofrequency Ablation for Initial Recurrent Hepatocellular Carcinoma After Curative Treatment: Comparison With Primary Cases

European Journal of Radiology
MedicineNuclear MedicineRadiologyImaging
2015English

Multimodality Treatment With Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma

Digestion
Gastroenterology
2012English

Yttrium-90 Radioembolization Versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Comparative Analysis

HPB
HepatologyGastroenterology
2016English

Proton Beam Therapy for Locally Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation or Transcatheter Arterial Chemoembolization

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Comparison of Outcomes Between SBRT, Yittrium-90 Radioembolization, Transarterial Chemoembolization, and Radiofrequency Ablation as Bridge to Transplant for Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy